33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II biomarker analysis of sorafenib (BAY 43-9006) in patients with advanced hepatocellular carcinoma
    Meeting Abstract

    Abou-Alfa, G. K.; Schwartz, L.; Ricci, S.; Amadori, D.; Santoro, A.; Figer, A.; de Greve, J.; Douillard, J. Y.; Taylor, I.; Moscovici, M.; more...
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • Combined electron and photon intensity modulated radiotherapy for the management of malignant pleural mesothelioma
    Meeting Abstract

    Chan, M.; Chui, C.; Song, Y.; Burman, C.; Schupak, K.
    Medical Physics (2005)

    Fulltext@MSK | Save
  • High dose chemoradiotherapy and ASCT can overcome the prognostic importance of bcl-2, bim, and p53 in relapsed/refractory Hodgkin's lymphoma
    Meeting Abstract

    Persky, Daniel; Teruya-Feldstein, Julie; Kewalramani, Tarun; Bonner, Pauline D; Iasonos, Alexia; Rice, David; Yahalom, Joachim; Nimer, Stephen D; Zelenetz, Andrew D; Moskowitz, Craig H.
    Blood (2005)

    Fulltext@MSK | Save
  • The utility of consolidative upfront high dose chemoradiotherapy and ASCT in patients with mantle cell lymphoma (MCL)
    Meeting Abstract

    Persky, Daniel; Portlock, Carol S.; Lessac-Chenen, Simone; Iasonos, Alexia; Zelenetz, Andrew D; Kewalramani, Tarun; Rice, David; Yahalom, Joachim; Nimer, Stephen D; Moskowitz, Craig H.
    Blood (2005)

    Fulltext@MSK | Save
  • Vaccination with MAGE-3 protein can induce a potent immune response in a healthy donor which can be adoptively transferred via stem cell transplant (Tx) to a multiple myeloma (MM) patient
    Meeting Abstract

    Gnjatic, Sacha; Szmania, Susann; Moreno, Amberly; Cottler-Fox, M.; Shaughnessy, John; Barlogie, Bart; Old, Lloyd; Tricot, Guido; van Rhee, Frits
    Blood (2005)

    Fulltext@MSK | Save
  • Drug-induced cutaneous vasculitis in patients with non-Hodgkin's lymphoma receiving bortezomib: A possible surrogate marker of response
    Meeting Abstract

    Gerecitano, J.; Goy, A.; Macgregor-Cortelli, B.; Neylon, E.; Wright, J.; Esseltine, D.; Schenkein, D.; Gonen, M.; O'Connor, O. A.
    Blood (2005)

    Fulltext@MSK | Save
  • The impact of protein profiling using antibody arrays in cancer research
    Meeting Abstract

    Sanchez Carbayo, M.
    Tumor Biology (2005)

    Fulltext@MSK | Save
  • Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays
    Meeting Abstract

    Sanchez Carbayo, M.; Socci, N.; Lozano, J.; Saint, F.; Cordon-Cardo, C.
    Tumor Biology (2005)

    Fulltext@MSK | Save
  • Changing concepts in breast cancer surgery
    Meeting Abstract

    Cody, H. S.
    EJC Supplements (2004)

    Fulltext@MSK | Save
  • Transcriptional regulation of androgen receptor gene expression in prostate cancer
    Meeting Abstract

    Zhang, L.
    Cancer Research (2004)

    Fulltext@MSK | Save